does retatrutide make you nauseous side effects: GI, heart, skin & long-term risk How Does Retatrutide Make You
Description
Retatrutide is a novel triple receptor agonist peptide developed by Eli Lilly that simultaneously targets the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R)
Interested in learning more about GLP-1based weight management options
Conclusion There are many ways to increase your GLP-1 levels
SCFAs activate free fatty acid receptors FFAR2 and FFAR3 on L-cells, thereby stimulating GLP-1 secretion
Measuring their activity provides valuable insights into metabolic function and therapeutic potential
doi: 10.1210/endo.141.7.7536
